Skip to main content

TCR2 Therapeutics Inc.

TCRRDelisted Jun 1, 2023
Industry
Biological Products, (No Diagnostic Substances)
SEC CIK
0001750019

TCR2 Therapeutics Inc. was delisted on Jun 1, 2023; its insiders filed their last Form 4 on Feb 14, 2024; 59 institutions reported holding it in 13F filings for Q1 2023, worth $31.5M in total; no superinvestor held it.

Q3 2022 vs. Q2 2022

How the institutions holding TCR2 Therapeutics Inc. changed between Q2 2022 and Q3 2022.

All holders in Q3 2022All holders in Q2 2022

13F holders of TCRR: Q2 2022 compared with Q3 2022
MeasureQ2 2022Q3 2022Change
Holders8381−2
Shares24.9M25.0M+155.0K (+0.6%)
Value$72.2M$45.1M−$27.1M (−37.6%)

New holders (11)

Institutions that held TCR2 Therapeutics Inc. at the end of Q3 2022 but not at the end of Q2 2022.

Institutions new to TCRR in Q3 2022
InstitutionSharesValue% of portfolio
AlphaCentric Advisors LLC151,000$272.0K0.28%
Jacobs Levy Equity Management, Inc83,360$150.0K0.00%
UBS Oconnor LLC54,035$97.0K0.00%
Public Employees Retirement System of Ohio18,863$34.0K0.00%
Connor, Clark & Lunn Investment Management Ltd.14,362$26.0K0.00%
Belvedere Trading LLC16,316$26.0K0.03%
Aquatic Capital Management LLC13,400$24.0K0.00%
Newman Dignan & Sheerar, Inc.11,522$21.0K0.01%
UBS Group AG3,699$7.00K0.00%
Point72 Hong Kong Ltd1,741$3.00K0.00%
China Universal Asset Management Co., Ltd.361$1.00K0.00%

Sold out (13)

Institutions that held TCR2 Therapeutics Inc. at the end of Q2 2022 and filed for Q3 2022 without it.

Institutions that sold out of TCRR in Q3 2022
InstitutionShares, Q2 2022Value, Q2 2022
Charles Schwab Investment Management Inc177,081$514.0K
Squarepoint Ops LLC29,030$84.0K
Deutsche Bank AG19,706$57.0K
Nan Fung Group Holdings Ltd19,335$56.0K
XTX Topco Ltd18,568$54.0K
Orion Portfolio Solutions, LLC13,485$39.0K
Group One Trading, L.P.587$2.00K
New York State Common Retirement Fund270$1.00K
Captrust Financial Advisors200$1.00K
Ellevest, Inc.258$1.00K
Howe & Rusling Inc50$0
Credit Suisse AG16$0
Capital Advisors, Ltd. LLC50$0